Antimicrobial peptides: A systemic failure of industrial antibiotic pipelines obscures ancient microbial warfare solutions
Original framing: “Bacteria-killing polymers—a new class of antibiotic?” — Phys.org
Indigenous knowledge systems globally document AMPs in medicinal practices, from the *rongoā* of Māori (e.g., *harakeke* fiber extracts) to the *tsamai* (medicinal mud) of the San people, which contain peptide-rich microbial communities. Colonial health systems systematically suppressed these practices, labeling them ‘unscientific’ while patenting isolated compounds—e.g., the 1990s bioprospecting of *Propolis* by Swiss pharmaceuticals, derived from Indigenous beekeeping knowledge. The omission of these systems reinforces the myth of Western science as the sole source of medical innovation, obscuring how Indigenous stewardship of microbial ecosystems could accelerate AMP deployment today.
The AMP narrative is a classic example of **scientific colonialism**—where a 3.
5-billion-year-old microbial dialogue is reframed as a ‘new’ human invention, obscuring both Indigenous stewardship and the structural failures that created the resistance crisis. The pharmaceutical industry’s historical resistance to natural compounds (e.g., penicillin’s suppression by synthetics) mirrors today’s reluctance to scale AMPs, not due to technical limits but **patentability constraints** and **agribusiness lobbying**. Cross-cultural evidence—from Ayurveda’s *amla* to the San’s *tsamai*—demonstrates that microbial balance, not eradication, is the key, yet the narrative treats AMPs as a linear ‘fix’ rather than a systemic restoration. The trickster here is capitalism, which has repeatedly co-opted ecological knowledge while claiming ‘originality,’ as seen in the patenting of *neem* extracts. True solutions require **decolonizing research**, **regulating industrial agriculture**, and **reimagining antibiotics as part of a regenerative health system**—not as weapons, but as allies in a restored microbial web.